Hazama Shoichi

Affiliate Master Yamaguchi University

A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer

Journal of Immunotherapy : official journal of the Society for Biological Therapy Volume 37 Issue 1 Page 36-42

published_at 2014-01

Title

A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer

Creators Suzuki Nobuaki

Creators Hazama Shoichi

Creators Ueno Tomio

Creators Matsui Hiroto

Affiliate Master Yamaguchi University

[kakenhi]15501 grid.268397.1

Creators Shindo Yoshitaro

Creators Iida Michihisa

Creators Yoshimura Kiyoshi

Creators Yoshino Shigefumi

Creators Takeda Kazuyoshi

Creators Oka Masaaki

Creator Keywords

pancreatic cancer peptide KIF20A phase I immunotherapy

Languages eng

Resource Type journal article

Publishers Raven Press Lippincott Williams & Wilkins

Date Issued 2014-01

File Version Not Applicable (or Unknown)

Access Rights metadata only access

Relations

[ISSN]1524-9557

[NCID]AA10794609

[NCID]AA12551619

[PMID]info:pmid/24316554

info:doi/10.1097/CJI.0000000000000012

[isVersionOf] [URI]http://journals.lww.com/immunotherapy-journal/pages/default.aspx

Schools 大学院医学系研究科（医学）医学部附属病院